These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14964580)

  • 1. Mitral regurgitation disappearance after cibenzoline treatment in a patient with hypertrophic obstructive cardiomyopathy.
    Inada K; Komukai K; Mori C; Nagasawa H; Shibata T; Mochizuki S
    Intern Med; 2004 Jan; 43(1):55-8. PubMed ID: 14964580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.
    Hamada M; Shigematsu Y; Inaba S; Aono J; Ikeda S; Watanabe K; Ogimoto A; Ohtsuka T; Hara Y; Higaki J
    Circ J; 2005 Aug; 69(8):940-5. PubMed ID: 16041163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cibenzoline therapy for mitral regurgitation in patients with HOCM.
    Hamada M
    Intern Med; 2004 Jan; 43(1):3-4. PubMed ID: 14964571
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
    Hamada M; Ikeda S; Ohshima K; Nakamura M; Kubota N; Ogimoto A; Shigematsu Y
    J Cardiol; 2016 Mar; 67(3):279-86. PubMed ID: 26116980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
    Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
    J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
    Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
    Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
    Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
    Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles.
    Hamada M; Aono J; Ikeda S; Watanabe K; Inaba S; Suzuki J; Ohtsuka T; Shigematsu Y
    Circ J; 2007 Oct; 71(10):1540-4. PubMed ID: 17895548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip.
    Schäfer U; Frerker C; Thielsen T; Schewel D; Bader R; Kuck KH; Kreidel F
    EuroIntervention; 2015 Dec; 11(8):942-7. PubMed ID: 25169590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.
    Hang D; Schaff HV; Nishimura RA; Lahr BD; Abel MD; Dearani JA; Ommen SR
    J Am Soc Echocardiogr; 2019 Mar; 32(3):333-340. PubMed ID: 30598365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated Mitral Valve Replacement was Effective in Patient with Hypertrophic Obstructive Cardiomyopathy and Concomitant Mitral Regurgitation;Report of a Case].
    Matsushiro T; Fujimatsu T; Miyaji K
    Kyobu Geka; 2019 Feb; 72(2):149-152. PubMed ID: 30772883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-onset systolic anterior motion of the mitral valve after aortic valve replacement for severe aortic stenosis.
    Dohi M; Doi K; Okawa K; Yamanami M; Yaku H
    Int Heart J; 2013; 54(5):292-6. PubMed ID: 24097219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic obstructive cardiomyopathy: the mitral valve could be the key.
    Dulguerov F; Marcacci C; Alexandrescu C; Chan KM; Dreyfus GD
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):61-5. PubMed ID: 26792931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Treatment for Hypertrophic Obstructive Cardiomyopathy with Concomitant Mitral Valve Abnormalities: A Cohort of 26 Cases.
    Song BR; Ren Y; Zhang HJ
    Heart Surg Forum; 2018 Nov; 21(6):E443-E447. PubMed ID: 30604666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities.
    Cui B; Wang S; Xu J; Wang W; Song Y; Sun H; Zheng Z; Lv F; Xiong H
    Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):722-6. PubMed ID: 26374266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Hamada M; Shigematsu Y; Hara Y; Suzuki M; Ohtsuka T; Hiasa G; Ogimoto A; Saeki H; Suzuki J; Hiwada K
    Jpn Circ J; 2001 Jun; 65(6):531-8. PubMed ID: 11407736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic obstructive cardiomyopathy with abnormalities of the mitral valve complex.
    Ohkado A; Kitamura M; Hachida M; Nishinaka T; Hanayama N; Sato W; Koyanagi H
    J Heart Valve Dis; 1997 Jan; 6(1):60-2. PubMed ID: 9044078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined anterior mitral valve leaflet retention plasty and septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
    Nasseri BA; Stamm C; Siniawski H; Kukucka M; Komoda T; Delmo Walter EM; Hetzer R
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1515-20. PubMed ID: 21570861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children.
    Delmo Walter EM; Siniawski H; Hetzer R
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):546-52. PubMed ID: 19464922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cibenzoline on regional left ventricular function in hypertrophic obstructive cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Hirao K; Iwado Y; Ohmori K; Matsuo H
    Clin Cardiol; 2000 Sep; 23(9):689-96. PubMed ID: 11016020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.